QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
OTCMKTS:PANC

Panacos Pharmaceuticals Stock Forecast, Price & News

$0.0040
-0.01 (-61.90 %)
(As of 02/24/2021 02:28 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.01
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.04
Volume212,600 shs
Average Volume136,306 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta6.62
Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PANC
CUSIPN/A
CIKN/A
Phone(617) 926-1551
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1808th out of 1,958 stocks

Biological Products, Except Diagnostic Industry

174th out of 177 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0040
-0.01 (-61.90 %)
(As of 02/24/2021 02:28 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PANC News and Ratings via Email

Sign-up to receive the latest news and ratings for PANC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Panacos Pharmaceuticals (OTCMKTS:PANC) Frequently Asked Questions

What stocks does MarketBeat like better than Panacos Pharmaceuticals?

Wall Street analysts have given Panacos Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Panacos Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Panacos Pharmaceuticals' key executives?

Panacos Pharmaceuticals' management team includes the following people:
  • John R. Barr, President & Chief Executive Officer
  • Thomas T. Higgins, Chief Financial Officer

Who are some of Panacos Pharmaceuticals' key competitors?

What is Panacos Pharmaceuticals' stock symbol?

Panacos Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PANC."

How do I buy shares of Panacos Pharmaceuticals?

Shares of PANC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Panacos Pharmaceuticals' stock price today?

One share of PANC stock can currently be purchased for approximately $0.00.

What is Panacos Pharmaceuticals' official website?

The official website for Panacos Pharmaceuticals is www.panacos.com.

Where are Panacos Pharmaceuticals' headquarters?

Panacos Pharmaceuticals is headquartered at 134 COOLIDGE AVE, WATERTOWN MA, 02472.

How can I contact Panacos Pharmaceuticals?

Panacos Pharmaceuticals' mailing address is 134 COOLIDGE AVE, WATERTOWN MA, 02472. The company can be reached via phone at (617) 926-1551.


This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.